Peptide therapy claims on TikTok: what the science actually supports

What's this video probably claiming?

Dr. Sim Bhatti is a known peptide therapy advocate on social media, and based on the category context, this video likely promotes one or more bioactive peptides, possibly BPC-157, TB-500, or growth hormone secretagogues like CJC-1295 or ipamorelin, as tools for recovery, anti-aging, or performance. The framing on TikTok almost always follows a familiar script: these compounds do things pharmaceutical drugs cannot, they are "natural," and the medical establishment is either ignoring or suppressing them. Expect claims about accelerated healing, improved body composition, cognitive enhancement via peptides like semax or selank, or systemic benefits from copper peptides like GHK-Cu. Some creators in this space also conflate research-grade compounds with clinically validated treatments, which is a significant problem when the audience is deciding whether to purchase or self-administer.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you are asking about, and the evidence base is thinner than TikTok implies. BPC-157 has shown regenerative effects in rodent models, including accelerated tendon-to-bone healing (Gwyer et al., 2019, Current Pharmaceutical Design), but zero completed human randomized controlled trials exist as of 2024. TB-500, a synthetic fragment of thymosin beta-4, has similarly compelling animal data for cardiac and musculoskeletal repair, but human pharmacokinetic data is essentially absent from peer-reviewed literature. CJC-1295 combined with ipamorelin does stimulate growth hormone release in humans, with Walker et al. (2006, Journal of Clinical Endocrinology and Metabolism) showing GH pulse amplification, but translating elevated GH into meaningful clinical outcomes requires much longer study durations than any existing trial provides. GHK-Cu shows in-vitro collagen stimulation data, but topical versus systemic bioavailability remains poorly characterized.

Where does the social media noise diverge from clinical reality?

The gap is large, and it matters. TikTok peptide content routinely presents rodent data as if it directly translates to human dosing and outcomes. It does not. A rat healing faster after BPC-157 injection tells you something interesting about a mechanism, not a treatment protocol. There is also a regulatory reality that gets ignored entirely: BPC-157, TB-500, and several other peptides have been removed from the FDA's bulk compounding list under 503A pharmacy regulations, meaning compounded versions are operating in legal gray territory in the United States as of 2024. Creators rarely mention this. MK-677, sometimes grouped with peptides, is actually a non-peptide ghrelin mimetic and is not approved for any human indication. Semax and selank are registered drugs in Russia with some published clinical data, but that data has not been replicated in Western regulatory-standard trials. The stack culture, combining multiple peptides simultaneously, has no safety data whatsoever.

What should you actually know?

If you are considering peptide therapy after watching content like this, the most important thing to understand is the difference between biological plausibility and clinical evidence. Many of these compounds have real mechanisms worth studying. That is not the same as them being proven, safe, or legally obtainable in a pharmaceutical-grade form. A 2023 analysis by Cohen et al. (JAMA Internal Medicine) flagged multiple compounded peptide products for contamination and dosing inaccuracies. The FDA's 2024 guidance on BPC-157 specifically cited lack of safety data for systemic use. Working with a licensed telehealth provider who orders through a legitimate 503B outsourcing facility, where applicable, is categorically different from sourcing peptides labeled "research use only." The latter is not a medical treatment. Anyone claiming otherwise is either misinformed or selling something.